AzTrials
AzTrials

Inguinal Hernia RepairNCT07602647

Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Undergoing Elective Inguinal Hernia Repair

An observational study of Inguinal Hernia Repair, run by Fudan University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

To evaluate the clinical characteristics, postoperative outcomes, and factors associated with Clavien-Dindo grade ≥II complications in nonagenarians undergoing elective inguinal hernia repair. Read more about this study

Who is it for?
Ages 90 years and older
Conditions the study is for
Inguinal Hernia Repair
How many people
150 participants
Where
No sites listed yet
Study dates
1 Jun 2026to 15 Jun 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 90 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients aged 90 years or older who underwent elective inguinal hernia repair

Inclusion Criteria: patients aged 90 years or older who underwent elective inguinal hernia repair -

Exclusion Criteria: Patients underwent emergency surgery for incarcerated or strangulated hernia. Patients were also excluded if incomplete data, or valid follow-up information was unavailable.

-

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Undergoing Elective Inguinal Hernia Repair: A Single-Center Retrospective Cohort Study

To evaluate the clinical characteristics, postoperative outcomes, and factors associated with Clavien-Dindo grade ≥II complications in nonagenarians undergoing elective inguinal hernia repair. Preoperative, intraoperative, and postoperative data of nonagenarians who underwent elective inguinal hernia repair were collected. The primary outcome was Clavien-Dindo grade ≥II complications. Univariable logistic regression was used to identify associated factors.

Read the detailed description

We included patients aged 90 years or older who underwent elective inguinal hernia repair at Huadong Hospital, Fudan University, between 2013 and 2025. Patients were excluded if they underwent emergency surgery for incarcerated or strangulated hernia. Patients were also excluded if incomplete data, or valid follow-up information was unavailable.

Patient data were collected from inpatient medical records, anesthesia records, nursing records, and follow-up records. Preoperative variables included age, sex, body mass index, functional status, American Society of Anesthesiologists class, comorbidities, and hernia-related characteristics. Intraoperative variables included anesthesia type, operative time, surgical approach, procedure type, mesh use, concomitant procedures, drain placement, and urinary catheterization. Postoperative variables included length of hospital stay, postoperative intensive care unit admission, postoperative complications, 30-day readmission, 30-day reoperation, in-hospital mortality, 30-day mortality, recurrence, chronic pain, reoperation for recurrence, and all-cause mortality during follow-up.

Keywords
Inguinal hernia, nonagenarians, Clavien-Dindo classification, functional status, mesh repair
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07602647
Study groupRoleWhat they receive
nonagenarianselective inguinal hernia repair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clavien-Dindo grade ≥II complications

    The Clavien-Dindo classification grades complications according to the intensity of treatment required. Grade II or higher complications generally include events requiring pharmacologic therapy, interventional treatment, surgery, or resulting in death.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2026
  2. Study start1 Jun 2026 (estimated)
  3. Primary completion14 Jun 2026 (estimated)
  4. Study completion15 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07602647
Sponsor's protocol ID
HuadongHosptialHernia03
Status last verified
May 2026
First submitted
16 May 2026
Last updated
22 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Inguinal Hernia Repair, run by Fudan University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact HEKAI SHI (+8618580290227, 25111280019@m.fudan.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clavien-Dindo grade ≥II complications (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in